Tower Research Capital LLC (TRC) - COCRYSTAL PHARMA INC ownership

COCRYSTAL PHARMA INC's ticker is and the CUSIP is 19188J409. A total of 18 filers reported holding COCRYSTAL PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q2 2024$8,577
-17.8%
3,681
-50.6%
0.00%
Q1 2024$10,439
+3.7%
7,456
+27.6%
0.00%
Q4 2023$10,063
+60.7%
5,844
+74.6%
0.00%
Q3 2023$6,261
-53.3%
3,348
-40.4%
0.00%
Q2 2023$13,415
+78811.8%
5,613
-35.1%
0.00%
-100.0%
Q1 2023$17
+70.0%
8,651
+78.5%
0.00%
Q4 2022$104,8470.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
VIMA LLC 225$3870.00%
ROYAL BANK OF CANADA 9$00.00%
VANGUARD GROUP INC 275,656$474,7350.00%
FMR LLC 4$70.00%
BANK OF AMERICA CORP /DE/ 8,979$15,4620.00%
WELLS FARGO & COMPANY/MN 92$1590.00%
NORTHERN TRUST CORP 12,207$21,0230.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 167$2880.00%
NVWM, LLC 84$1450.00%
View complete list of COCRYSTAL PHARMA INC shareholders